CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-08-20 | NEIS JOHN Director | Purchase · Stock Purchase Warrant (right to buy) | +130,000 | $0.01 | $1K | 130,000 |
| 2014-08-20 | NEIS JOHN Director | Sale · Convertible Debenture (right to buy) | −50,000 | $3.75 | $188K | 0 |
| 2014-08-20 | NEIS JOHN Director | Purchase · Stock Purchase Warrant (right to buy) | +138,711 | $0.01 | $1K | 268,711 |
| 2014-08-20 | Pedder Simon President and CEO | Purchase | +13,300 | $3.75 | $50K | 13,300 |
| 2014-08-20 | Pedder Simon President and CEO | Purchase · Stock purchase warrant (right to buy) | +13,300 | $0.01 | $133 | 277,578 |
| 2014-08-20 | HILL STEPHEN A Director | Purchase | +5,300 | $3.75 | $20K | 5,300 |
| 2014-08-20 | HILL STEPHEN A Director | Purchase · Stock purchase warrant (right to buy) | +5,300 | $0.01 | $53 | 21,351 |
| 2014-08-19 | MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner | Purchase | +65,687 | $3.05 | $200K | 1,136,487 |
| 2014-08-18 | MARXE AUSTIN W & GREENHOUSE DAVID M 10% owner | Purchase | +4,800 | $3.05 | $15K | 1,070,800 |
Page 12 of 12 · 229 trades